|
 |
PRODUCTS |
|
|
SANPA |
|
SANPA 10 mg TABLET |
Therapeutical Group |
Alimentary tract and metabolism
|
ATC Code |
A10X |
|
Active Substance |
ASPARTAME
|
|
Presentation |
Tablets |
|
|
|
|
|
SANPA 20 mg TABLET |
Therapeutical Group |
Alimentary tract and metabolism
|
ATC Code |
A10X |
|
Active Substance |
ASPARTAME
|
|
Presentation |
Tablets |
|
|
|
|
|
 |
SEFAGEN |
|
SEFAGEN 0.5 g ENJEKTABL FLAKON IM/IV |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD01 |
|
Active Substance |
CEFOTAXIME SODIUM
|
|
Presentation |
Injectabl vial |
|
|
|
|
|
SEFAGEN 1 g ENJEKTABL FLAKON IM/IV |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD01 |
|
Active Substance |
CEFOTAXIME SODIUM
|
|
Presentation |
Injectabl vial |
|
|
|
|
|
 |
SEFBAKTAM |
|
SEFBAKTAM 1 g ENJEKTABL FLAKON |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01DD12 |
|
Active Substance |
CEFOPERAZONE SODIUM
SULBACTAM SODIUM
|
|
Presentation |
Injectabl vial |
|
|
|
|
|
 |
SEKROL |
|
SEKROL PEDİATRİK ŞURUP |
Therapeutical Group |
Respiratory system
|
ATC Code |
R05CB06 |
|
Active Substance |
AMBROXOL HCL
|
|
Presentation |
Syrup |
|
|
|
|
|
SEKROL 30 mg/5 mL ŞURUP |
Therapeutical Group |
Respiratory system
|
ATC Code |
R05CB06 |
|
Active Substance |
AMBROXOL HCL
|
|
Presentation |
Syrup |
|
|
|
|
|
SEKROL 30 mg TABLET |
Therapeutical Group |
Respiratory system
|
ATC Code |
R05CB06 |
|
Active Substance |
AMBROXOL HCL
|
|
Presentation |
Tablets |
|
|
|
|
|
 |
SİLİNA |
|
SİLİNA 125 mg/5 mL SÜSPANSİYON İÇİN KURU TOZ |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01CA01 |
|
Active Substance |
AMPICILLIN
|
|
Presentation |
Suspension |
|
|
|
|
|
SİLİNA 250 mg/5 mL SÜSPANSİYON İÇİN KURU TOZ |
Therapeutical Group |
Antiinfectives for systemic use
|
ATC Code |
J01CA01 |
|
Active Substance |
AMPICILLIN
|
|
Presentation |
Suspension *Yurtdışı |
|
|
|
|
|
 |
SİPROGUT |
|
SİPROGUT % 0.3 GÖZ DAMLASI |
Therapeutical Group |
Sensory organs
|
ATC Code |
S01AX13 |
|
Active Substance |
CIPROFLOXACIN
|
|
Presentation |
Eye drops |
|
|
|
|
|
SİPROGUT % 0.3 KULAK DAMLASI |
Therapeutical Group |
Sensory organs
|
ATC Code |
S02AA15 |
|
Active Substance |
CIPROFLOXACIN
|
|
Presentation |
Ear drops |
|
|
|
|
|
 |
SPAZMOTEK |
|
SPAZMOTEK IM/IV sc ENJ. İÇİN SOLÜSYON İÇEREN AMPUL |
Therapeutical Group |
Alimentary tract and metabolism
|
ATC Code |
A03BB01 |
|
Active Substance |
HYOSCINE N-BUTYLBROMIDE
|
|
Presentation |
Ampoule *Yurtdışı |
|
|
|
|
|
 |
SPAZMOTEK PLUS |
|
SPAZMOTEK PLUS FİLM KAPLI TABLET |
Therapeutical Group |
Alimentary tract and metabolism
|
ATC Code |
A03DB04 |
|
Active Substance |
HYOSCINE N-BUTYLBROMIDE
PARACETAMOL
|
|
Presentation |
Film coated tablets *Yurtdışı |
|
|
|
|
|
 |
STİDERM |
|
STİDERM JEL |
Therapeutical Group |
Dermatologicals
|
ATC Code |
D04AB01 |
|
Active Substance |
MEPYRAMINE MALEATE, LIDOCAIN HYDROCHLORIDE, DEXPANTHENOL
|
|
Presentation |
Gel |
|
|
|
|
|
 |
|
|
|